|
|
|
LifeScienceHistory.com - Check us out on Instagram
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
MannKind Corporation
| | | Phone: | (818) 661-5000 | Year Established: | 1991 | Employees: | 125 | Ticker: | MNKD | Exchange: | NASDAQ | Main Contact: | Michael Castagna, CEO | | Other Contacts: | Patrick McCauley, J.D., M.B.A., CCO Courtney Barton, CCEP, CIPP (US/E), Chief Compliance & Privacy Officer Joseph Kocinsky, CTO Rose Alinaya, Senior VP & Principal Accounting Officer Steven Binder, CFO David M. Kendall, MD,, CMO David Thomson, VP, General Counsel & Corporate Secretary
| | Company Description | MannKind Corporation focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes and cancer. Its pipeline includes AFRESA, which has completed Phase 3 clinical trials, and MKC253, which is currently in phase 1 clinical trials. Both of these investigational products are being evaluated for their safety and efficacy in the treatment of diabetes. | |
|
|
|
|
|